"Follow-Up Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Descriptor ID |
D005500
|
MeSH Number(s) |
E05.318.760.500.750.249 N05.715.360.775.175.250.350 N06.850.520.450.500.750.350
|
Concept/Terms |
Follow-Up Studies- Follow-Up Studies
- Follow Up Studies
- Follow-Up Study
- Studies, Follow-Up
- Study, Follow-Up
- Followup Studies
- Followup Study
- Studies, Followup
- Study, Followup
|
Below are MeSH descriptors whose meaning is more general than "Follow-Up Studies".
Below are MeSH descriptors whose meaning is more specific than "Follow-Up Studies".
This graph shows the total number of publications written about "Follow-Up Studies" by people in this website by year, and whether "Follow-Up Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 59 | 59 |
1996 | 0 | 44 | 44 |
1997 | 0 | 58 | 58 |
1998 | 0 | 51 | 51 |
1999 | 0 | 59 | 59 |
2000 | 0 | 59 | 59 |
2001 | 0 | 68 | 68 |
2002 | 0 | 60 | 60 |
2003 | 0 | 53 | 53 |
2004 | 0 | 54 | 54 |
2005 | 0 | 58 | 58 |
2006 | 0 | 105 | 105 |
2007 | 0 | 97 | 97 |
2008 | 0 | 98 | 98 |
2009 | 0 | 79 | 79 |
2010 | 0 | 73 | 73 |
2011 | 0 | 119 | 119 |
2012 | 0 | 120 | 120 |
2013 | 0 | 115 | 115 |
2014 | 0 | 131 | 131 |
2015 | 0 | 131 | 131 |
2016 | 0 | 115 | 115 |
2017 | 1 | 112 | 113 |
2018 | 0 | 142 | 142 |
2019 | 0 | 145 | 145 |
2020 | 0 | 111 | 111 |
2021 | 0 | 75 | 75 |
2022 | 0 | 30 | 30 |
2023 | 0 | 22 | 22 |
2024 | 0 | 61 | 61 |
2025 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Follow-Up Studies" by people in Profiles.
-
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program. Inflamm Bowel Dis. 2025 Apr 10; 31(4):923-934.
-
Reproductive and Hormonal Factors and Thyroid Cancer Risk: Pooled Analysis of Prospective Cohort Studies in the Asia Cohort Consortium. Cancer Prev Res (Phila). 2025 Apr 01; 18(4):209-221.
-
Poor Olfaction and Risk of Stroke in Older Adults: The Atherosclerosis Risk in Communities Study. Stroke. 2025 Feb; 56(2):465-474.
-
Extensive Disease and Exposure to Multiple Biologics Precolectomy Is Associated with Endoscopic Cuffitis Post-Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis. Inflamm Bowel Dis. 2025 01 06; 31(1):72-76.
-
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium. Inflamm Bowel Dis. 2025 01 06; 31(1):131-139.
-
Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2025 01 06; 31(1):63-71.
-
Tailoring Kidney Transplant Strategies: Unraveling the Impact of Acute Kidney Injury and Preservation Methods Across Different Strata of Kidney Risk. Clin Transplant. 2025 Jan; 39(1):e70078.
-
Priming and task-specific training for arm weakness post stroke: A randomized controlled trial. Ann Clin Transl Neurol. 2025 Jan; 12(1):192-202.
-
Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data. Ann Surg Oncol. 2025 Mar; 32(3):2045-2055.
-
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.